These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 10938396

  • 1. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
    Riva C, Lavieille JP, Schmerber S, Cuisnie O, Reyt E.
    Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
    [Abstract] [Full Text] [Related]

  • 2. Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinoma.
    Bensmaine M el-A, Guillot T, Bernal ET, Janot F, Sigal R, Domenge C, Wibault P, Armand JP, Cvitkovic E.
    Am J Clin Oncol; 1996 Aug; 19(4):356-62. PubMed ID: 8677904
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
    Schneider M, Etienne MC, Milano G, Thyss A, Otto J, Dassonville O, Mobayen H, Saudes L, Guillot T, Demard F.
    J Clin Oncol; 1995 Jul; 13(7):1656-62. PubMed ID: 7602355
    [Abstract] [Full Text] [Related]

  • 4. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F, Comella P, Marcolin P, Russo Spena F, Biglietto M, Cartenì G, De Lucia L, Avallone A, Gravina A, Comella G.
    Cancer; 1999 Feb 15; 85(4):952-9. PubMed ID: 10091775
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.
    Cancer Chemother Pharmacol; 2008 Dec 15; 63(1):9-17. PubMed ID: 18343925
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin, 5-fluorouracil, and high-dose folinic acid in patients with advanced unresectable head and neck cancer.
    Alba E, Sanchez-Chaparro MA, Alonso L, Ribelles N, Ramon Delgado J, Rueda A, Pablo Tenllado P, Solano J, Urquiza R.
    Am J Clin Oncol; 1996 Apr 15; 19(2):140-3. PubMed ID: 8610637
    [Abstract] [Full Text] [Related]

  • 7. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.
    Oral Oncol; 2006 Aug 15; 42(7):675-84. PubMed ID: 16731029
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.
    Hitt R, Jimeno A, Millán JM, Castellano D, Cortés-Funes H.
    Cancer; 2004 Aug 15; 101(4):768-75. PubMed ID: 15305408
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM.
    Cancer J Sci Am; 1997 Aug 15; 3(2):92-9. PubMed ID: 9099459
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F, Rosati G, De Rosa P, Avallone A, De Rosa V, De Lucia L, Comella P, Comella G.
    Oncology; 2002 Aug 15; 63(3):232-8. PubMed ID: 12381902
    [Abstract] [Full Text] [Related]

  • 11. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas.
    Iop A, Cartei G, Vigevani E, Clocchiatti L, Mansutti M, Sibau AM.
    Am J Clin Oncol; 1997 Oct 15; 20(5):515-8. PubMed ID: 9345340
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG).
    Caponigro F, Comella P, Rivellini F, Avallone A, Budillon A, Di Gennaro E, Mozzillo N, Ionna F, De Rosa V, Manzione L, Comella G.
    Ann Oncol; 2000 May 15; 11(5):575-80. PubMed ID: 10907951
    [Abstract] [Full Text] [Related]

  • 13. Induction chemotherapy with docetaxel, cisplatin, fluorouracil and l-leucovorin for locally advanced head and neck cancers: a modified regimen for Japanese patients.
    Watanabe A, Taniguchi M, Sasaki S.
    Anticancer Drugs; 2003 Nov 15; 14(10):801-7. PubMed ID: 14597874
    [Abstract] [Full Text] [Related]

  • 14. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
    Colevas AD, Busse PM, Norris CM, Fried M, Tishler RB, Poulin M, Fabian RL, Fitzgerald TJ, Dreyfuss A, Peters ES, Adak S, Costello R, Barton JJ, Posner MR.
    J Clin Oncol; 1998 Apr 15; 16(4):1331-9. PubMed ID: 9552034
    [Abstract] [Full Text] [Related]

  • 15. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH, Chan WK, Shu CH, Law CK, Chen SY, Yen SH, Chen KY.
    Cancer; 1995 Dec 01; 76(11):2186-92. PubMed ID: 8635020
    [Abstract] [Full Text] [Related]

  • 16. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M, Taguchi T.
    Cancer Chemother Pharmacol; 2007 May 01; 59(6):789-94. PubMed ID: 17053926
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Hussain M, Benedetti J, Smith RE, Rodriguez GI, Schuller D, Ensley J.
    Cancer; 1995 Oct 01; 76(7):1233-7. PubMed ID: 8630903
    [Abstract] [Full Text] [Related]

  • 18. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 19. Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck.
    Colevas AD, Norris CM, Tishler RB, Fried MP, Gomolin HI, Amrein P, Nixon A, Lamb C, Costello R, Barton J, Read R, Adak S, Posner MR.
    J Clin Oncol; 1999 Nov 01; 17(11):3503-11. PubMed ID: 10550148
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G, Ghiani M, Lai P, Maccio A, Dessi D, Succu G, Massa D, Curreli L, Mulas C, Esu S, Proto E, Cadeddu G, Tore G.
    Oncol Rep; 1998 Nov 01; 5(6):1499-505. PubMed ID: 9769395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.